Mark Voll

CFO

Equibles does not estimate personal net worth.

Get an email with a short summary when RenovoRx, Inc. publishes a filing, an earnings call transcript or a press release.

Get RNXT alerts

About Mark Voll

Mark Voll is recorded as CFO at RenovoRx, Inc. (RNXT). The newest filing on record that lists Mark Voll as CFO at RenovoRx, Inc. (RNXT) is dated April 30, 2026. RenovoRx, Inc. reported in an 8-K filed February 6, 2026 that Mark Voll was appointed Chief Financial Officer, effective February 4, 2026. Mark Voll has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for RenovoRx, Inc. on August 12, 2026. RenovoRx, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at RenovoRx, Inc. includes Shaun Bagai (CEO and Board Member), Shaun R. Bagai (CEO and Board Member), Ramtin Agah (Chairman) and 7 others.

“On February 4, 2026, the Board appointed Mark Voll, a consultant to the Company, as the Company's Chief Financial Officer, effective immediately.”

RenovoRx, Inc. Form 8-K, filed February 6, 2026 · Read the filing

Mark Voll on recent calls

“Thank you, Rampton, and good afternoon, everyone. the second quarter was a strong quarter for Renovo RX, and the financial results reflect meaningful progress on our commercial plan.”

CFO, Second Quarter 2026 Financial Results Conference Call · August 12, 2026

“So when we look at our market and our business, we believe it's a high-margin, large market opportunity for our standalone device.”

CFO, iAccess Alpha Virtual Best Ideas Summer Investement Conference 2026 · June 23, 2026

“The first quarter of 2026 was Renovo Rx's strongest quarter for revenue to date, and the financial results reflect meaningful progress in implementing our commercial plan.”

CFO, RenovoRx, Inc. Q1 FY2026 Earnings Call · May 14, 2026